Nitya Ray compensation by year
Actinium Pharmaceuticals Summary Compensation Table · all 2 fiscal years held| Component | FY2017 | FY2018 |
|---|---|---|
| Salary | $177,273 | $323,331 |
| Bonus | $0 | $35,000 |
| Stock awards | $0 | $0 |
| Option awards | $198,896 | $41,194 |
| Non-equity incentive | $0 | $0 |
| Pension and deferred compensation | $0 | $0 |
| All other | $0 | $0 |
| Total | $376,169 | $399,525 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Actinium Pharmaceuticals, Inc. DEF 14A filed November 25, 2019, accession 0001213900-19-024628, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Actinium Pharmaceuticals, Inc. filed document, accession 0001213900-19-024628. Every figure is read from that document and cited to the page and table it appears in. Filed November 25, 2019.
Actinium Pharmaceuticals’s named executive officers, FY2018
as the company reported each| Named executive officer | Role | FY2018 total |
|---|---|---|
| Sandesh Seth | Chairman and Chief Executive Officer | $1,374,253 |
| Mark Berger | Chief Medical Officer | $612,313 |
| Anil Kapur | Chief Commercial Officer | $505,663 |
| Steve O’Loughlin | Chief Financial Officer | $505,552 |
| Dale Ludwig | Chief Scientific Officer | $424,695 |
| Nitya Ray · this page | Former Executive Vice President (5) | $399,525 |
The full Actinium Pharmaceuticals compensation record
free company briefThis page is one person within Actinium Pharmaceuticals's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Actinium Pharmaceuticals's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.